SNDX R&D Expenses
Syndax Pharmaceuticals Inc · R&D Expenses
SNDX R&D Expenses
Latest reported$261.80Mperiod ending
SNDX TTM R&D Expenses ($3.21M → $261.80M)
TTM R&D Expenses
High-resolution chart · PNG
SNDX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 261,802,000 | |
| 255,993,000 | |
| 258,784,000 | |
| 245,672,000 | |
| 260,363,000 | |
| 246,791,000 | |
| 241,647,000 | |
| 231,244,000 | |
| 199,360,000 | |
| 185,469,000 | |
| 163,031,000 | |
| 139,746,000 | |
| 127,560,000 | |
| 122,530,000 | |
| 118,498,000 | |
| 110,557,000 | |
| 109,262,000 | |
| 96,399,000 | |
| 88,247,000 | |
| 79,869,000 | |
| 68,671,000 | |
| 62,743,000 | |
| 50,435,000 | |
| 44,415,000 | |
| 39,930,000 | |
| 41,277,000 | |
| 42,994,000 | |
| 49,313,000 | |
| 53,485,000 | |
| 56,046,000 | |
| 60,106,000 | |
| 60,884,000 | |
| 58,977,000 | |
| 53,988,000 | |
| 48,201,000 | |
| 40,076,000 | |
| 40,162,000 | |
| 36,431,000 | |
| 31,665,000 | |
| 25,778,000 | |
| 16,472,000 | |
| 12,612,000 | |
| 9,549,000 | |
| 8,417,000 | |
| 7,158,000 | |
| 9,761,000 | |
| 10,175,000 | |
| 9,779,000 | |
| 8,915,000 | |
| 4,772,000 | |
| 3,208,000 | |
| 2,149,544 |